Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LBR | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | LIMA1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | CDT1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | S100PBP | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | PDCD11 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | CNBP | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | GAREM2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | SPATA20 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-07 |
mRNA | HNRNPA3 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | ARID2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |